Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Validate RAGE-Seq for cultured E. coli DH5a

PROVIDER: PRJNA574284 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10189379_1.fastq.gz	Fastqsanger.gz
	SRR10189379_2.fastq.gz	Fastqsanger.gz
	SRR10189380_1.fastq.gz	Fastqsanger.gz
	SRR10189380_2.fastq.gz	Fastqsanger.gz
	SRR10189381_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Project description:Validate RAGE-Seq for cultured E. coli ATCC35218

| PRJNA574296 | ENA

Project description:Validate RAGE-Seq workflow using clinical UTI sample, U84

| PRJNA574291 | ENA

Infection with Salmonella or Pseudomonas or E. coli - Interactions between plants and human pathogenic bacteria.

Project description:au07-07_salmonella - infection with Salmonella or Pseudomonas or E. coli. Identification of genes involved in early Arabidopsis response to pathogenic and non-pathogenic bacteria. Arabidopsis thaliana Col-0 seedlings were infected for 2 hours with a) Salmonella typhimurium strain 14028s, b) Pseudomonas syringae DC3000 or c) Escherichia coli DH5A Keywords: treated vs untreated comparison

2010-03-25 | GSE20996 | GEO

Infection with Salmonella or Pseudomonas or E. coli - Interactions between plants and human pathogenic bacteria.

2010-06-05 | E-GEOD-20996 | biostudies-arrayexpress

Nonpathogenic E. coli displaying decoy-resistant IL18 mutein enhance the efficacy of cancer immunotherapies

Project description:The tumor microenvironment can inhibit the efficacy of cancer therapies through mechanisms such as poor trafficking and exhaustion of immune cells. To address this challenge, we exploited the safety, tumor tropism, and ease of genetic manipulation of non-pathogenic Escherichia coli (E. coli) to deliver key immune-activating cytokines to tumors via surface display on the outer membrane of E. coli K-12 DH5a. Non-pathogenic E.coli expressing murine decoy-resistant IL18 mutein (DR18) induced robust CD8+ T and NK cell-dependent immune responses and suppressed tumor progression in immune-competent colorectal carcinoma and melanoma mouse models. E. coli K-12 DH5a engineered to display human DR18 potently activated mesothelin-targeting CAR NK cells and enhance their trafficking into tumors, which extended survival in an NK cell treatment-resistant mesothelioma xenograft model by enhancing TNFa signaling and upregulating NK activation markers. Our live bacteria-based immunotherapeutic system safely and effectively induces potent anti-tumor responses in treatment-resistant solid tumors, motivating further evaluation of this approach in the clinic.

2024-08-22 | GSE275391 | GEO

Escherichia coli breed:DH5a

Project description:Escherichia coli breed:DH5a Proteome

| PRJNA471563 | ENA

Project description:RACE-Seq for E. coli DH5a, w/o oil

| PRJNA573541 | ENA

Project description:Benchmarking of FISH-RACS-Seq targeting Escherichia coli K-12 DH5a

| PRJNA891066 | ENA

Guzior et al - C. perfringens BSH/T

Project description:E. coli DH5a expressing bile salt hydrolase variants in the presence of 1 mM glycocholate (GCA), taurocholate (TCA), or cholate (CA).

2023-06-09 | MSV000092138 | MassIVE

Escherichia coli strain:DH5a

Project description:Escherichia coli strain:DH5a Genome sequencing and assembly

| PRJNA521426 | ENA